Giving sight to the developing world

Article

OTE's Victoria Farrell interviews Cambodian paediatric ophthalmologist Phara Khauv to find out how an ORBIS initiative has impacted his practice in a vastly underserved country.

Key Points

Preventable blindness still affects an unacceptably high proportion of the world's population. The World Health Organization estimates that 28 million of the world's 37 million blind suffer from preventable blindness: that's a staggering 75.7% of the world's total population of blind people. The vast majority of the needlessly blind - 90% in fact - live in the developing world.

In 1982, a non-profit organization, ORBIS International was established. The goal of the organization is to increase access to vision care services in these countries, with the goal of eventually eliminating preventable blindness.

The fellowship programme

In addition to the training programmes and the services provided by the Flying Eye Hospital, ORBIS also, in collaboration with its partner FedEx, offers fellowships to ophthalmologists from developing regions.














The programme was launched in 2006; three fellows have since been named and have undertaken courses, and a further two will be designated annually for the next five years.

Previous FedEx Fellows include Dr Thomas Cherian of the Little Flower Hospital in Kerala, India, who completed his fellowship in the areas of retina, paediatric retina and retinopathy of prematurity at Moorfields Eye Hospital, UK, and Dr Nguyen Thanh Chi of Vietnam's Da Nang Eye Hospital, who studied paediatric ophthalmology at Stanford University, US.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.